Informed deferral: A moral requirement for entry into the hepatitis C virus treatment warehouse†
Potential conflict of interest: Dr. Jensen consults for and received grants from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Genentech, and Tibotec. He consults for Astex, Biotica, Gilead, Inhibitex, and Merck. He also have others interests with Consensus Medical Communication and Clinical Care Options.
No abstract is available for this article.